<DOC>
	<DOCNO>NCT00003817</DOCNO>
	<brief_summary>RATIONALE : Pressure nerve stimulation apply acupuncture point inside wrist may help control nausea vomit chemotherapy . PURPOSE : Randomized phase II trial study effectiveness acupressure acustimulation wrist band treat nausea vomit patient undergoing chemotherapy cancer .</brief_summary>
	<brief_title>Acupressure Acustimulation Wrist Bands Prevention Nausea Vomiting Caused Chemotherapy</brief_title>
	<detailed_description>OBJECTIVES : I . Evaluate efficacy acupressure acustimulation adjunct standard serotonin antiemetic reduce acute nausea ( day treatment ) delay nausea ( 1-4 day follow treatment ) associate cisplatin doxorubicin base chemotherapy cancer patient . II . Evaluate efficacy acupressure acustimulation reduce acute delay vomit improve quality life cancer patient . III . Investigate relationship expectation development chemotherapy-related nausea/vomiting actual occurrence cancer patient . OUTLINE : This randomize study . Patients stratify accord chemotherapy agent research site . Patients randomize one three treatment arm . Arm I : Patients receive standard antiemetic therapy serotonin receptor antagonist . Arm II : Patients receive standard antiemetic therapy serotonin receptor antagonist wear acupressure wrist band ( elastic band equip small plastic button use apply pressure specific point wrist ) continuously 5 consecutive day except necessary avoid immersion water . Patients may wear band either wrist , include alternate wrist desire . Arm III : Patients receive standard antiemetic therapy serotonin receptor antagonist wear acustimulation wrist band ( portable transcutaneous electrical nerve stimulator ( TENS ) device ) continuously 5 consecutive day except necessary avoid immersion water . Patients may wear band either wrist , include alternate wrist desire , may adjust intensity stimulation optimum effectiveness . All patient complete questionnaire concern expectation nausea side effect prior receive chemotherapy cisplatin doxorubicin . Patients arm II III complete measure wrist band position . All patient complete questionnaire 5 day diary home concern nausea emesis follow first chemotherapy treatment , complete quality life questionnaire fourth day follow treatment . PROJECTED ACCRUAL : A total 700 patient accrue study 3 year .</detailed_description>
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Granisetron</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<mesh_term>Dolasetron</mesh_term>
	<mesh_term>Tropisetron</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis cancer No symptomatic brain metastasis PATIENT CHARACTERISTICS : Age : 18 Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Cardiovascular : No cardiac pacemaker Other : No clinical evidence current impend bowel obstruction Able understand English PRIOR CONCURRENT THERAPY : Biologic therapy : No concurrent interferon Chemotherapy : No prior chemotherapy Concurrent cisplatin doxorubicin base chemotherapy require No multiple day dose cisplatin , doxorubicin , hexamethylmelamine , dacarbazine , nitrosourea streptozocin Other concurrent chemotherapy allow 1 multiple day Endocrine therapy : Not specify Radiotherapy : No concurrent radiotherapy Surgery : Not specify Other : Serotonin receptor antagonist antiemetic ( ondansetron , granisetron , tropisetron , dolasetron mesylate ) require</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
	<keyword>nausea vomit</keyword>
</DOC>